ADAM17 anticorps (N-Term)
Aperçu rapide pour ADAM17 anticorps (N-Term) (ABIN2196010)
Antigène
Voir toutes ADAM17 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 202-232, N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- ADAM17, NT (ADAM17, CSVP, TACE, Disintegrin and metalloproteinase domain-containing protein 17, Snake venom-like protease, TNF-alpha convertase, TNF-alpha-converting enzyme, CD156b)
-
Purification
- Purified by peptide immunoaffinity chromatography.
-
Immunogène
- ADAM17 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 202~232 amino acids from the N-terminal region of human ADAM17.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- ADAM17 (ADAM Metallopeptidase Domain 17 (ADAM17))
-
Autre désignation
- ADAM17
-
UniProt
- P78536
-
Pathways
- Signalisation Notch, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Response to Growth Hormone Stimulus
Antigène
-